Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Amyotrophic Lateral Sclerosis Market Qualitative Insights Key Enhancement & Share Analysis to 2027|Brainstorm Cell Therapeutics, Sanofi, Biogen
09:31am, Friday, 24'th Dec 2021 OpenPR
The market is being driven by a growing senior population, increased awareness of ALS, and an increasing incidence rate. The high cost of ALS therapy, on the other hand, may be an obstacle to the market throughout the projection period. North
Multiple Sclerosis Drugs Market is Projected to Showcase Significant Growth up to 2027 Covid-19 Analysis | Sanofi, Bayer
08:49am, Friday, 24'th Dec 2021 OpenPR
This Multiple Sclerosis Drugs market report, additionally notices effect of developments on the future progression of the market. Numerous new terms presented in the report are passage hindrances, exchanging strategies and monetary and customary concerns. Get the complete sample, please
Recent Insulin Glargine Biosimilar Developments
05:58pm, Thursday, 23'rd Dec 2021 JD Supra
On Monday the FDA approved Eli Lillys insulin glargine biosimilar Rezvoglar, a biosimilar to Sanofis Lantus. Rezvoglar is indicated to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. By: Goodwin
Nonselective Agonists Market Size Comprehensive Analysis, Growth Forecast from 2019 to 2027 | Pfizer, Sanofi, Novartis, Sterimax
02:17pm, Thursday, 23'rd Dec 2021 OpenPR
Los Angeles, United State, ,- This research study is one of the most detailed and accurate ones that solely focus on the global Nonselective Agonists market. It sheds light on critical factors that impact the growth of the global Nonselective
Auto Injectors Market to Witness Lucrative Growth USD 7,894.6 Million by 2028 | Sanofi, Pfizer, Mylan N.V., Novartis International AG
10:06am, Thursday, 23'rd Dec 2021 OpenPR
New Research Study ""Auto Injectors Market 2021 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight The global Auto Injectors market was valued at US$ 1,904.1 Mn
Pharming Group N.V.: Pharming Group and Sanofi renew strategic manufacturing partnership agreement
06:04am, Thursday, 23'rd Dec 2021 FinanzNachrichten
The company extends its existing 11-year partnership with Sanofi with an additional 5 years The company will no longer pursue the realization of its downstream production facility and will be savi
American Finance Trust To Sell Sanofi''s US Headquarters in New Jersey
07:41pm, Wednesday, 22'nd Dec 2021 CoStar
The $261 Million Sale To Fund Purchase of Retail Centers
Sterile Injectable Drugs Market Recent Trends, Future Growth Analysis Forecasts 2027|Baxter International, Sanofi, GlaxoSmithKline
11:54am, Wednesday, 22'nd Dec 2021 OpenPR
The global Sterile Injectable Drugs market was valued at 3462.53 Million USD in 2020 and will grow with a CAGR of 5.16% from 2021 to 2027. Over the forecast period, the market demand for injectable anti-cancer medications is likely to
Sanofi Acquiring Amunix Pharmaceuticals for $1B
11:32am, Wednesday, 22'nd Dec 2021 Smarter Analyst
This article was originally published on TipRanks.com Sanofi (SNYNF) has reached an agreement to acquire Amunix Pharmaceuticals, Inc. The post Sanofi Acquiring Amunix Pharmaceuticals for $1B appeared first on Smarter Analyst .
Nanoemulsion Market Report 2022-2029 to Witness Increase in Revenues by Top Companies like AbbVie, Sanofi, Fresenius Kabi, Allergan, Novartis
09:25am, Wednesday, 22'nd Dec 2021 OpenPR
A market study Global Nanoemulsion Market examines the performance of the Nanoemulsion market 2022. It encloses an in-depth analysis of the Nanoemulsion market state and the competitive landscape globally. Nanoemulsion report analyzes the prospect of Nanoemulsion market in the present
Sanofi: Information concerning the total number of voting rights and shares - NOVEMBER 2021
08:52pm, Tuesday, 21'st Dec 2021 Intrado Digital Media
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de lAutorité des Marchés Financiers (Regulation of the French stock market authority)
Sanofi to buy PE-backed Amunix Pharmaceuticals
04:54pm, Tuesday, 21'st Dec 2021 PE Hub
Sanofi has agreed to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company.
STAT+: Pharmalittle: Moderna says booster shot raises antibody levels to thwart Omicron; Sanofi buys yet another biotech
02:16pm, Tuesday, 21'st Dec 2021 STAT News
Moderna (MRNA) disclosed that a booster shot of its coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant.
Sanofi (SNY) to Acquire Amunix, Boost Immuno-oncology Pipeline
01:05pm, Tuesday, 21'st Dec 2021
Sanofi (SNY) inks a deal to acquire privately-held Amunix Pharmaceuticals, which will add potentially transformative cancer therapies to its immuno-oncology pipeline.
Sanofi Agrees To Buy US-Based Amunix Pharma For $1B Upfront
07:01am, Tuesday, 21'st Dec 2021
Sanofi SA (NASDAQ: SNY) will buy an immuno-oncology company, Amunix Pharmaceuticals Inc, for an upfront payment of about $1 billion. Sanofi will also pay Amunix up to $225 million based on certain
